Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- ViiV Healthcare receives EU marketing authorisation for Juluca (dolutegravir/rilpivirine), the first 2-drug regimen, once-daily, single-pill for the treatment of HIV
- GSK receives US approval of Arnuity Ellipta for use in children from 5 years old who suffer from asthma
- Nucala (mepolizumab) study reports long-term safety data, consistent exacerbation reduction and improved asthma control
Tweets from GSK
-
GSK @GSK
In the next 12 months alone, vaccinations will save the lives of more than two million children #vaccinateforlife
about 10 hours ago -
GSK @GSK
Are you between the ages of 17-24 with a learning disability and interested in joining a one-year work experience programme? Applications for Project Search are open until 27 June: gsk.to/1YF5BsU
about 13 hours ago
-
GSK @GSK
We’re looking forward to the American Thoracic Society annual conference @atscommunity! Honoured to join the conversation with the world’s leading #respiratory scientists #ATS2018. Follow us on @GSK_conferences.
about 3 days ago
